[1]
Yuniza, Melani, Ratna Maila Dewi Anggraini, and Yenny Dian Andayani, “Efficacy and Safety of IL-5 Pathway-Targeting Biologics (Mepolizumab, Reslizumab, Benralizumab) in the Management of Hypereosinophilic Syndromes: A Systematic Review and Meta-Analysis”, OAIJMR, vol. 5, no. 5, pp. 1481-1500, Jul. 2025.